Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$411,382
-$58,256 QoQ
Shares Held
17,084
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1,887
of 2,821 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Provenance Wealth Advisors, LLC holds $3,356,958 across 12 Drug Manufacturers - General names. PFE ranks #2 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,052 | $1,283,056 | |
| 2 | PFE |
Pfizer Inc
This page
|
17,084 | $411,382 | |
| 3 | ABBV |
AbbVie Inc.
|
1,565 | $393,816 | |
| 4 | OGN |
Organon & Co.
|
25,758 | $348,763 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,619 | $330,884 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,532 | $196,862 | |
| 7 | AMGN |
Amgen Inc
|
519 | $187,940 | |
| 8 | NVS |
Novartis AG
|
637 | $99,830 |
All Filings in PFE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,382 | 17,084 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $469,638 | 16,725 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $416,452 | 16,725 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $426,153 | 16,725 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $410,746 | 16,945 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $583,833 | 23,040 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $719,705 | 27,128 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $1,671,921 | 57,772 | Shares | Sole | 2025-08-15 | |
| 2024-06-30 | $1,596,762 | 57,068 | Shares | Sole | 2025-08-15 | |
| 2024-03-31 | $1,591,962 | 57,368 | Shares | Sole | 2025-08-15 | |
| 2023-12-31 | $1,179,065 | 40,954 | Shares | Sole | 2025-08-15 | |
| 2023-09-30 | $28,161 | 849 | Shares | Sole | 2025-08-15 | |
| No filing history on record for this holder in this stock. | ||||||